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Infections are defined as clinically significant disease based on clinical and laboratory diagnosis, except in the case of virus infections, where the distinction between infection and symptomatic infection or disease is made. ....
Throat washings, urine samples, and blood buffy coats were obtained routinely for cytomegalovirus (CMV) and herpes simplex virus (HSV) cultures weekly for the first 8 postoperative weeks, biweekly during the third month, and monthly thereafter. Serum samples were obtained, ~ when possible, from recipients and donors prior to transplantation and from recipients at monthly intervals after transplantation. CMV and Epstein-Barr virus CEBV) serology were performed as previously described."
...... Table 2 is a summary of infections in all the 1981-1983 groups. Consider first the renal <{/1 groups. The percent of patients who had at . least one infection, as well as mean episodes of infection per patient, was significantly higher 'Q in the randomized azathioprine group (88% ~ and 2.18) than in the CsA group (61 % and 0.98). None of the infections in the renal groups was associated with deaths, of which ~J~_ there was only one.
RESULTS
The cardiac and liver transplant groups on CsA had more infection than the renal group _. , , _ on esA immunosuppression. The sites ot infections in the kidney, heart, and liver groups varied (Table 3) . Most frequent infections for the 3 groups, respectively, were urinary tract, pulmonary and intrathoracic, and abdominal and gastrointestinal infections. Kidney recipients had the lowest frequency of "!l" -bacteremias. Only the liver group had fUL gemia. Perhaps more important is the fact that mortality associated with severe infec-: tions was significant in the heart and live ... ~ groups. Many of the liver group died acutel~ with many infections. This is reflected in tt fact that 50% of all episodes of infection W'2 . ' acquired I month after liver transplantatiOl To reach the same proportion, cardiac '-patients took 3 months, (2) Gram-positive infections, parti,;ularly staphylococcal infections, were more common in the randomized AZA group than all other groups on CsA. (3) Severe fungus infections were a serious problem only in the liver transplant patients. Forty-four percent of liver patients had serious fungal infections and 16% were fungemic. The most common agent was Candida, which caused serious infections in 15 patients. Of these, 3 had disseminated disease, 6 had fungemia, 7 had abdominal, and 3 had lung and chest infections. Four patients had aspergillosis, in whom one produced dissemination and 3 produced pneumonia or chest infections. There was one severe Mucor wound infection and one crypto-')ccal meningitis. (4) Symptomatic viral nfections, included here under "other," were a problem in cardiac transplant patients and are discussed below. Renal patients on AZA had more infections that were more severe and were predominately Staphylococcal ( 2 The two AZA groups had 29% and 39% pneumonias, as opposed to 8% for the CsA group. Stap'lylococcal penumonias and bacteremias were ak:l more common in patients on AZA. In contrast, the incidence of non-life-threatening urinary tract infections were almost identical: 41%, 39%, and 42% (not shown in tab;e). Pneumocystis pneumonia, however, may be a special problem in renal patients on CsA. Our total Pittsburgh incidence rates for the AZA and CsA groups prior to the institution trimethoprim-sulfa prophylaxis in September 1982 were 3.4% and 9.0%, respectively, which are significantly different. This problem is discussed by Hardy et al. elsewhere in this issue. Virus infections, particularly of the herpesvirus group (CMV, HSV, VZV, and EBV' are frequent occurrences after organ transplantation. 5 In previous experience, the degreeand type of immunosuppression has been crit; cal in determining the morbidity. In renal transplant recipients, antithymocyte globulin has been associated with more symptomatic infection. 6 Primary infections, i.e., those -I/T (%). infected/total evaluable (%).
rSy. symptomatic patients.
occurring in seronegative recipients, have been iound to be more symptomatic. 7 Hvrpesvirus infections in our transplant groups are presented in Table 6 . The first row describes all CMV infections diagnosed by isol2 ting the virus from routine throat, urine, or bood buffy coat specimens. The majority of p2tients became infected, and the rates are ndistinguishable from results from previous c:'e:; of patients, most of whom were on A£:A. As a group of agents, herpesviruses and gram-negative aerobes are the most frequent causes of symptomatic infections. , The incidence of CMV viremia varied from 21'-% to 62%. All patients who had symptomatic CMV infection were viremic, but there ,./ere also many viremic patients who were not symptomatic. The percent of patients with symptomatic disease due to CMV and herpes-,-uses in general was significantly higher in .::~ cardiac group. They also had more viremia due to CMV.
Of the patients with symptomatic CMV ., ,xtion, there were three cases of CMV ::umonitis in the renal group on CsA. the ten symptomatic cases in the cardiac group were associated with CMV in the lung. One was found in association with pneumocystis in a lung biopsy and four were found at autopsy. There were 12 symptomatic cases in the liver group, including one case of interstitial pneumonia and three instances of dissemi-,nated disease found at autopsy. Primary and reactivation CMV infections are listed in Table 7 . Except for a suggestion in the case of cardiac transplant recipients that primary infection in previously seronegative subjects resulted in more symptomatic infection than reactivation infection, the numbers are too small to incriminate primary more than reactivation infections in symptomatic disease.
Rates for EBV infection are shown in Table  8 . Cardiac transplant recipients had more infection, and only they had probable symptomatic disease due to EBV (see Dummer et aI., this issue). However, our total experience is stilI rela tivel y small.
SUMMARY AND CONCLUSIONS
Renal patients on CsA had fewer bacteremias, pneumonias, and gram-positive staphylococcal infections than renal patients on Almost every patient was infected with CMV; 8%-34% developed symptomatic disease. This was always associated with vire-~ mla.
Heart transplant recipients developed more CMV viremia and more EBV infection. They also had more symptomatic disease from all ... herpesviruses.
